Höglund P, Glas R, Ohlén C, Ljunggren H G, Kärre K
Department of Tumor Biology, Karolinska Institutet, Stockholm, Sweden.
J Exp Med. 1991 Aug 1;174(2):327-34. doi: 10.1084/jem.174.2.327.
The mechanism behind natural tumor resistance conveyed by a H-2Dd transgene to C57Bl/6 (B6) mice was investigated. Transgenic D8 mice were more efficient than control mice in natural killer (NK) cell mediated rapid elimination of intravenously inoculated radiolabeled lymphoma cells of B6 origin, such as RBL-5. There was no difference between D8 and B6 mice when elimination of YAC-1 targets was monitored. The effect of the transgene on the NK repertoire was related to the H-2 phenotype of the target: the differential elimination of RBL-5 lymphoma cells in D8 and B6 mice was not seen when a H-2 deficient variant of this line was used (efficiently eliminated in both genotypes), nor was it seen with a H-2Dd transfectant (surviving in both genotypes). The data show that a MHC class I transgene can directly control natural killing in vivo by altering the repertoire rather than the general levels of NK activity. Since the NK mediated elimination seen after introduction of a novel gene in the host was neutralized by introducing the same gene (H-2Dd), but not an unrelated class I gene (H-2Dp), in the tumor, the data support the concept of NK surveillance against missing self. This combined transgenic/transfectant system may serve as a tool for a molecular dissection of the interactions between NK cells and their targets in vivo.
研究了由H - 2Dd转基因赋予C57Bl/6(B6)小鼠的天然肿瘤抗性背后的机制。转基因D8小鼠在自然杀伤(NK)细胞介导的快速清除静脉注射的源自B6的放射性标记淋巴瘤细胞(如RBL - 5)方面比对照小鼠更有效。监测YAC - 1靶标的清除时,D8和B6小鼠之间没有差异。转基因对NK细胞库的影响与靶标的H - 2表型有关:当使用该品系的H - 2缺陷变体时(在两种基因型中均能有效清除),在D8和B6小鼠中未观察到RBL - 5淋巴瘤细胞的差异清除,使用H - 2Dd转染细胞时(在两种基因型中均存活)也未观察到差异清除。数据表明,MHC I类转基因可通过改变细胞库而非NK活性的总体水平直接在体内控制自然杀伤作用。由于在宿主中引入新基因后观察到的NK介导的清除作用在肿瘤中通过引入相同基因(H - 2Dd)而非无关的I类基因(H - 2Dp)而被中和,这些数据支持了NK监视缺失自我的概念。这种转基因/转染细胞联合系统可作为一种工具,用于在体内对NK细胞与其靶标之间的相互作用进行分子剖析。